The technology behind URIBX
A "lab on a chip" liquid biopsy that combines proprietary One-X polymer chemistry with AI Software to read cancer biomarkers directly from urine — rapid point-of-care (POC) results within minutes.
One-X Polymer
A proprietary polymer that selectively binds tumour-derived metabolites in the urine matrix and converts the binding into a precise absorbance signal.
AI Software
On-device AI Software interprets the optical signal and returns a quantitative, clinically validated cancer present / not present result.
Multidisciplinary R&D
Ten years of research combining chemistry, biotechnology, materials science and physics into a single chair-side workflow.
Rapid point-of-care (POC) results within minutes.
No waiting days for a lab. UriBx delivers a clear yes/no answer chair-side, within minutes — so you can act on the same visit.
Same-visit answers mean treatment can start weeks earlier — when outcomes are best.
- Sample to result in a single appointment — no courier, no lab queue.
- Runs chair-side on standard clinic equipment, with no specialist training.
- One clear yes/no readout you can discuss with the owner before they leave.